We confirmed that expression of cardiac NF‐κB p65 gradually increased along with CH development, which was strongly inhibited by administration of celecoxib in a time‐dependent manner (Fig. 7E and F). The gene discussed is NFKB1; the disease is cyclic hematopoiesis.